The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia

Research output: Contribution to journalLetter

Details

Authors
Organisations
External organisations
  • Lund University
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Article number5
JournalBlood Cancer Journal
Volume9
Issue number2
Publication statusPublished - 2019
Publication categoryResearch
Peer-reviewedYes